Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial

Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients

(2013) Kari R. Nations et al.   Drugs in research & development

A Translational Approach to Evaluate the Efficacy and Safety of the Novel AMPA Receptor Positive Allosteric Modulator Org 26576 in Adult Attention-Deficit/Hyperactivity Disorder

(2012) Lenard A. Adler et al.   BIOLOGICAL PSYCHIATRY

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of Two Selective Serotonin Reuptake Inhibitor Antidepressants, Sertraline and Escitalopram, on Aldosterone/Renin Ratio in Normotensive Depressed Male Patients

(2011) Ashraf H. Ahmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Translational PK–PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576

(2011) Roberta Bursi et al.   PSYCHOPHARMACOLOGY

The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments

(2010) Martin Bares et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A cognitive neuropsychological model of antidepressant drug action

(2010) A. Pringle et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats

(2009) Eugene Hamlyn et al.   BEHAVIOURAL PHARMACOLOGY

The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients

(2009) Richard Tranter et al.   JOURNAL OF AFFECTIVE DISORDERS

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

(2009) Andrew F. Leuchter et al.   PSYCHIATRY RESEARCH

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study

(2009) Andrew F. Leuchter et al.   PSYCHIATRY RESEARCH

Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus

(2009) Xiaowei W. Su et al.   PSYCHOPHARMACOLOGY

Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications

(2008) Srijan Sen et al.   BIOLOGICAL PSYCHIATRY

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder

(2008) Martin Bares et al.   EUROPEAN PSYCHIATRY

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

(2008) Francesco Matrisciano et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

(2007) Sungho Maeng et al.   BIOLOGICAL PSYCHIATRY